Paper2348469
Phase I trial of 5-day continuous venous infusion of oxaliplatin at circadian rhythm-modulated rate compared with constant rate.
Caussanel JP and 8 others. J Natl Cancer Inst, 1990. Cited by 231 papers, by iCite.
Cite this record
ConductScience Library. Phase I trial of 5-day continuous venous infusion of oxaliplatin at circadian rhythm-modulated rate compared with constant rate. Papers, record 2348469. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2348469
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Agents | Major topic |
| Circadian Rhythm | Major topic |
| Neoplasms | Major topic |
| Organoplatinum Compounds | Major topic |
| Adult | |
| Aged | |
| Drug Administration Schedule | |
| Drug Evaluation | |
| Female | |
| Humans | |
| Infusions, Intravenous | |
| Male | |
| Middle Aged | |
| Oxaliplatin | |
| Platinum |
Source PubMed
Cited by57
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 231 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42238520 | Chronotherapeutic administration of neoadjuvant chemotherapy reduces cancer-related fatigue-like behavior. | Brain Behav Immun Health | 2026 | https://conductscience.org/library/papers/42238520 | PubMed |
| 42201461 | High-dose dexamethasone and prolonged infusion time prevent oxaliplatin-related hypersensitivity reactions in patients with metastatic colorectal cancer. | Int J Clin Oncol | 2026 | https://conductscience.org/library/papers/42201461 | PubMed |
| 41981628 | Advances in research on circadian rhythms and colorectal cancer. | BMC Med Genomics | 2026 | https://conductscience.org/library/papers/41981628 | PubMed |
| 41426165 | Efficacy and Safety of mFOLFOX-6 in Advanced Gastric Cancer: A Prospective Observational Study. | South Asian J Cancer | 2025 | https://conductscience.org/library/papers/41426165 | PubMed |
| 41403927 | Overall survival according to time-of-day of combined immuno-chemotherapy for advanced gastric cancer: a propensity score-matched analysis. | Front Immunol | 2025 | https://conductscience.org/library/papers/41403927 | PubMed |
| 41262576 | Chrono-Pharmacology for Cancer: Harnessing Circadian Regulations of the Cell Cycle and Immune Response Dynamics for Precision Therapy. | ACS Pharmacol Transl Sci | 2025 | https://conductscience.org/library/papers/41262576 | PubMed |
| 41031880 | Perturbation of the circadian clock in chronic diseases involving organ fibrosis. | J Clin Invest | 2025 | https://conductscience.org/library/papers/41031880 | PubMed |
| 39463009 | Circadian Rhythm Disruption in Cancer Survivors: From Oncogenesis to Quality of Life. | Cancer Med | 2024 | https://conductscience.org/library/papers/39463009 | PubMed |
| 39283505 | Oxaliplatin-induced peripheral neuropathy with hepatic arterial versus intravenous infusion in metastatic colorectal cancer. | Support Care Cancer | 2024 | https://conductscience.org/library/papers/39283505 | PubMed |
| 38834742 | Why does circadian timing of administration matter for immune checkpoint inhibitors' efficacy? | Br J Cancer | 2024 | https://conductscience.org/library/papers/38834742 | PubMed |
| 38720476 | Chronotoxici-Plate Containing Droplet-Engineered Rhythmic Liver Organoids for Drug Toxicity Evaluation. | Adv Sci (Weinh) | 2024 | https://conductscience.org/library/papers/38720476 | PubMed |
| 38585011 | Long-term survival, toxicities, and the role of chrono-chemotherapy with different infusion rates in locally advanced nasopharyngeal carcinoma patients treated with intensity-modulated radiation therapy: a retrospective study with a 5-year follow-up. | Front Oncol | 2024 | https://conductscience.org/library/papers/38585011 | PubMed |
| 38531662 | Impact of immunotherapy time-of-day infusion on survival and immunologic correlates in patients with metastatic renal cell carcinoma: a multicenter cohort analysis. | J Immunother Cancer | 2024 | https://conductscience.org/library/papers/38531662 | PubMed |
| 36291855 | Chronotherapy: Circadian Rhythms and Their Influence in Cancer Therapy. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/36291855 | PubMed |
| 34712105 | In Gastric Cancer Patients Receiving Neoadjuvant Chemotherapy Systemic Inflammation Response Index is a Useful Prognostic Indicator. | Pathol Oncol Res | 2021 | https://conductscience.org/library/papers/34712105 | PubMed |
| 33114254 | An Optimal Time for Treatment-Predicting Circadian Time by Machine Learning and Mathematical Modelling. | Cancers (Basel) | 2020 | https://conductscience.org/library/papers/33114254 | PubMed |
| 32778717 | Diurnal expression of MRP4 in bone marrow cells underlies the dosing-time dependent changes in the oxaliplatin-induced myelotoxicity. | Sci Rep | 2020 | https://conductscience.org/library/papers/32778717 | PubMed |
| 32226546 | Targeting REV-ERBα for therapeutic purposes: promises and challenges. | Theranostics | 2020 | https://conductscience.org/library/papers/32226546 | PubMed |
| 31390550 | Medicine in the Fourth Dimension. | Cell Metab | 2019 | https://conductscience.org/library/papers/31390550 | PubMed |
| 29276407 | Systemic immune-inflammation index as a useful prognostic indicator predicts survival in patients with advanced gastric cancer treated with neoadjuvant chemotherapy. | Cancer Manag Res | 2017 | https://conductscience.org/library/papers/29276407 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/2348469
GET https://conductscience.org/api/papers/v1/2348469/cited_by?page=2